Company: BDRX
Filing Date: 2025-05-12
Form Type: 424B3
Source: 0001214659-25-007340
Chunk: 0

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-05-12
Form: 424B3
Chunk 0
---
Filed Pursuant to Rule 424(b)(3)

Registration No. 333-279994

PROSPECTUS

<div align='center'>2,486,190,000 Ordinary Shares Representing 248,619 American Depositary Shares

___________________</div>

This prospectus relates to
the resale from time to time, by the selling shareholders identified in this prospectus, of up to an aggregate of 2,486,190,000 ordinary
shares, nominal value £0.00005 per share, or Ordinary Shares, of Biodexa Pharmaceuticals PLC, or the Company, represented by 248,619
American Depositary Shares, or Depositary Shares, consisting of (1) 2,421,630,000 Ordinary Shares represented by 242,163 Depositary Shares,
issuable upon the exercise of warrants issued in a May 2024 private placement, and (2) 64,560,000 Ordinary Shares represented by 6,456
Depositary Shares, issuable upon the exercise of warrant agent warrants issued in such private placement.

The selling shareholders
are identified in the table commencing on page 60. Each Depositary Share represents 10,000 Ordinary Shares. No Depositary Shares are being
registered hereunder for sale by us. We will not receive any proceeds from the sale of the Depositary Shares by the selling shareholders.
All net proceeds from the sale of the Ordinary Shares represented by Depositary Shares covered by this prospectus will go to the selling
shareholders. However, we may receive proceeds from any exercise of warrants held by selling shareholders. See “Use of Proceeds.”

The selling shareholders may
sell all or a portion of the Ordinary Shares represented by Depositary Shares from time to time in market transactions through any market
on which our Depositary Shares are then traded, in negotiated transactions or otherwise, and at prices and on terms that will be determined
by the then prevailing market price or at negotiated prices directly or through a broker or brokers, who may act as agent or as principal
or by a combination of such methods of sale. See “Plan of Distribution.”

Our Depositary Shares are listed on the NASDAQ Capital Market under the symbol “BDRX.”
The last reported closing price of our Depositary Shares on the NASDAQ Capital Market on May 8, 2025 was $1.40.

Investing in our securities involves risks. See “Risk Factors” beginning on page 9 of this prospectus for a discussion of the factors you